Abello Cristobal, A Harding Constanza, P Rios Alejandra, Guelfand Miguel
Pediatric Surgery Department, Clinica Cmipediatrica International, Barranquilla, Colombia.
Pediatric Surgery Department, Hospital Dr Exequiel González Cortés, Santiago, Chile.
J Pediatr Surg. 2021 May;56(5):1068-1075. doi: 10.1016/j.jpedsurg.2020.12.003. Epub 2020 Dec 13.
Giant omphaloceles can be a challenge for pediatric surgeons and neonatologists worldwide. It is a rare and low-frequency congenital anomaly with no standardized management schemes or treatment protocols. Over the past few decades, we have developed a simple and efficient staged management for giant omphaloceles that allows definitive closure in the neonatal period, the results of which we outline in this report.
With IRB approval, a retrospective and multicentric cohort study was carried out between 1994 and 2019 with patients with giant omphalocele defined as an abdominal wall defect greater than 5 cm in diameter and/or that contains more than 50% of the liver within the sac. We included all patients managed with the nonsurgical silo technique. Data on demographics, gestational age, associated malformations, amnion reduction and inversion time, anatomic closure, requirement of a mesh, intra- and post-silo complications, mortality and follow-up were collected. The technique consists of the construction of a silo with an adhesive hydrocolloid dressing (Duoderm) to achieve an omphalocele staged-reduction until complete abdominal reintegration of the liver and bowel preservation of the amnion sac. This also enables the simulation of abdominal closure before definitive surgical closure, being managed in the neonatal intensive care unit (NICU).
Forty patients, 21 of whom were female, were managed with this technique. The average weight was 2900 gs (890-3900), and the median gestational age was 38 weeks (28-40). In total, 37.5% of cases had an associated comorbidity. The average silo reduction time was 7.3 days (0-35), the average time of amnion inversion was 5 days (2-9), and the average time to closure was 14.6 days (6-38). Anatomical closure was achieved in 95% of cases. In 4 patients, an absorbable mesh was used to reinforce the anatomical closure, and in 2 patients (5%), a mesh (Dualmesh) was required to achieve an abdominal closure. There was no mortality associated with this nonsurgical silo technique. The average follow-up time was 60 (6 - 288) months.
The staged silo management of giant omphalocele in this series is safe and effective and reduces the time to closure and potential morbidity and mortality compared with traditional surgical or medical management.
巨大脐膨出对全球小儿外科医生和新生儿科医生来说都是一项挑战。它是一种罕见的低频先天性异常,没有标准化的管理方案或治疗协议。在过去几十年里,我们针对巨大脐膨出开发了一种简单有效的分期管理方法,可在新生儿期实现确定性闭合,本报告将概述其结果。
经机构审查委员会(IRB)批准,于1994年至2019年开展了一项回顾性多中心队列研究,将巨大脐膨出患者定义为腹壁缺损直径大于5厘米和/或囊内包含超过50%肝脏的患者。我们纳入了所有采用非手术袋状技术治疗的患者。收集了有关人口统计学、胎龄、相关畸形、羊膜复位和翻转时间、解剖闭合、补片需求、袋内置管期间及之后的并发症、死亡率和随访情况的数据。该技术包括用粘性水胶体敷料(Duoderm)构建一个袋状结构,以实现脐膨出的分期缩小,直至肝脏完全回纳入腹腔并保留羊膜囊内的肠管。这还能在确定性手术闭合前模拟腹壁闭合,在新生儿重症监护病房(NICU)进行处理。
40例患者采用了该技术治疗,其中21例为女性。平均体重为2900克(890 - 3900克),中位胎龄为38周(28 - 40周)。总共有37.5%的病例存在相关合并症。袋状结构缩小的平均时间为7.3天(0 - 35天),羊膜翻转的平均时间为5天(2 - 9天),闭合的平均时间为14.6天(6 - 38天)。95%的病例实现了解剖闭合。4例患者使用了可吸收补片来加强解剖闭合,2例患者(5%)需要使用补片(双层补片)来实现腹壁闭合。该非手术袋状技术未导致死亡。平均随访时间为60(6 - 288)个月。
本系列中巨大脐膨出的分期袋状管理是安全有效的,与传统手术或保守治疗相比,缩短了闭合时间,降低了潜在的发病率和死亡率。